COL4A2 mutation associated with familial porencephaly and small-vessel disease

Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
European journal of human genetics: EJHG (Impact Factor: 4.23). 02/2012; 20(8):844-51. DOI: 10.1038/ejhg.2012.20
Source: PubMed

ABSTRACT Familial porencephaly, leukoencephalopathy and small-vessel disease belong to the spectrum of disorders ascribed to dominant mutations in the gene encoding for type IV collagen alpha-1 (COL4A1). Mice harbouring mutations in either Col4a1 or Col4a2 suffer from porencephaly, hydrocephalus, cerebral and ocular bleeding and developmental defects. We observed porencephaly and white matter lesions in members from two families that lack COL4A1 mutations. We hypothesized that COL4A2 mutations confer genetic predisposition to porencephaly, therefore we sequenced COL4A2 in the family members and characterized clinical, neuroradiological and biochemical phenotypes. Genomic sequencing of COL4A2 identified the heterozygous missense G1389R in exon 44 in one family and the c.3206delC change in exon 34 leading to frame shift and premature stop, in the second family. Fragmentation and duplication of epidermal basement membranes were observed by electron microscopy in a c.3206delC patient skin biopsy, consistent with abnormal collagen IV network. Collagen chain accumulation and endoplasmic reticulum (ER) stress have been proposed as cellular mechanism in COL4A1 mutations. In COL4A2 (3206delC) fibroblasts we detected increased rates of apoptosis and no signs of ER stress. Mutation phenotypes varied, including porencephaly, white matter lesions, cerebellar and optic nerve hypoplasia and unruptured carotid aneurysm. In the second family however, we found evidence for additional factors contributing to the phenotype. We conclude that dominant COL4A2 mutations are a novel major risk factor for familial cerebrovascular disease, including porencephaly and small-vessel disease with reduced penetrance and variable phenotype, which might also be modified by other contributing factors.

Download full-text


Available from: Daniel J Licht, Jun 13, 2015
1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Heterotrimers composed of collagen type IV alpha 1 (COL4A1) and alpha 2 (COL4A2) constitute one of the most abundant components of nearly all basement membranes. Accordingly, mutations in COL4A1 or COL4A2 are pleiotropic and contribute to a broad spectrum of disorders, including myopathy, glaucoma and hemorrhagic stroke. Here, we summarize the contributions of COL4A1 and COL4A2 mutations in human disease, integrate knowledge gained from model organisms and evaluate the implications for pathogenic mechanisms and therapeutic approaches.
    Human Molecular Genetics 08/2012; 21(R1):R97-R110. DOI:10.1093/hmg/dds346
  • [Show abstract] [Hide abstract]
    ABSTRACT: Mutations in COL4A1 have been identified in families with hereditary small vessel disease of the brain presumably due to a dominant negative mechanism. Here we report on two novel mutations in COL4A1 in two families with porencephaly, intracerebral hemorrhage and severe white matter disease caused by haploinsufficiency.Two families with various clinical presentations of cerebral microangiopathy and autosomal dominant inheritance were examined. Clinical, neuroradiological and genetic investigations were performed. Electron microscopy of the skin was also performed.In one of the families, sequence analysis revealed a one base deletion, c.2085del, leading to a frameshift and a premature stopcodon, p.(Gly696fs). In the other family, a splice site mutation was identified, c.2194-1G>A, which most likely leads to skipping of an exon with a frameshift and premature termination as a result. In fibroblasts of affected individuals from both families nonsense mediated decay of the mutant COL4A1 mRNAs and a clear reduction of COL4A1 protein expression was demonstrated, indicating haploinsufficiency of COL4A1. Moreover thickening of the capillary basement membrane in the skin was documented, similar to reports in patients with COL4A1 missense mutations.These findings suggest haploinsufficiency, a different mechanism than the commonly assumed dominant-negative effect, for COL4A1 mutations as a cause of (antenatal) intracerebral hemorrhage and white matter disease.
    Human Molecular Genetics 10/2012; DOI:10.1093/hmg/dds436
  • [Show abstract] [Hide abstract]
    ABSTRACT: The field of stroke genetics continues to make substantive advances. Large-scale partnerships have led to meta-analyses in ischemic and hemorrhagic stroke, which are yielding reproducible genetic risk factors. Most ischemic stroke risk factors seem to be specific to type, for example, large-vessel stroke. Progress is being made in understanding the pathophysiology of singlegene stroke syndromes. Genetics is also being used to potentially advance pharmacotherapeutics.
    Stroke 01/2013; 44(2). DOI:10.1161/STROKEAHA.111.000480